CMV-specific cytotoxic T lymphocytes
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CMV-specific cytotoxic T lymphocytes, covering 2017-07-02 to 2017-07-02. Get the full timeline:
Most recent: Clinical Trial Update: Cytomegalovirus (CMV) Specific Cytotoxic T Lymphocytes (CTL) When Used for Prophylaxis Against CMV in Recipients of Allogeneic, T Cell Depleted Stem Cell Transplants [Phase 1]